Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE Activated Protein C (aPC) TREATMENT IMPROVES MICROCIRCULATION IN SEVERE SEPSIS/ SEPTIC SHOCK SYNDROME

NCT01806428 is registered in ClinicalTrials.gov with Università Politecnica delle Marche as lead sponsor.

NCT NCT01806428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01806428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE Activated Protein C (aPC) TREATMENT IMPROVES MICROCIRCULATION IN SEVERE SEPSIS/ SEPTIC SHOCK SYNDROME
Lead sponsor
Università Politecnica delle Marche
Phase
Observational
Overall status
Completed
Start date
July 31, 2009
Completion date
August 31, 2011
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, severe sepsis